The BOLT chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BOLT chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The BOLT stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View BOLT Detailed Price Forecast - CNN Money | View BOLT Detailed Summary - Google Finance | ||
View BOLT Detailed Summary - Yahoo! Finance | View BOLT Stock Research & Analysis - Zacks.com |
View BOLT Trends & Analysis - Trade-Ideas | View BOLT Major Holders - Barrons | ||
View BOLT Call Transcripts - NASDAQ | View BOLT Breaking News & Analysis - Seeking Alpha | ||
View BOLT Annual Report - CompanySpotlight.com | View BOLT OTC Short Report - OTCShortReport.com | ||
View BOLT Fundamentals - TradeKing | View BOLT SEC Filings - Bar Chart | ||
View Historical Prices for BOLT - The WSJ | View Performance/Total Return for BOLT - Morningstar | ||
View the Analyst Estimates for BOLT - MarketWatch | View the Earnings History for BOLT - CNBC | ||
View the BOLT Earnings - StockMarketWatch | View BOLT Buy or Sell Recommendations - MacroAxis | ||
View the BOLT Bullish Patterns - American Bulls | View BOLT Short Pain Metrics - ShortPainBot.com |
View BOLT Stock Mentions - StockTwits | View BOLT Stock Mentions - PennyStockTweets | ||
View BOLT Stock Mentions - Twitter | View BOLT Investment Forum News - Investor Hub | ||
View BOLT Stock Mentions - Yahoo! Message Board | View BOLT Stock Mentions - Seeking Alpha |
View Insider Transactions for BOLT - SECform4.com | View Insider Transactions for BOLT - Insider Cow | ||
View BOLT Major Holdings Summary - CNBC | View Insider Disclosure for BOLT - OTC Markets | ||
View Insider Transactions for BOLT - Yahoo! Finance | View Institutional Holdings for BOLT - NASDAQ |
View BOLT Stock Insight & Charts - FinViz.com | View BOLT Investment Charts - StockCharts.com | ||
View BOLT Stock Overview & Charts - BarChart | View BOLT User Generated Charts - Trading View |
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
Posted on Thursday March 21, 2024
– BDC-1001 (trastuzumab imbotolimod) Phase 2 studies in four HER2-positive tumor types advancing toward 2024 milestones– BDC-3042 Phase 1 study successfully cleared safety assessments in the first three dose level cohorts – Cash balance of $128.6 million as of December 31, 2023, anticipated to fund key milestones through late 2025 REDWOOD CITY, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapi
Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference
Posted on Tuesday February 27, 2024
REDWOOD CITY, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced that management will present a company overview at the TD Cowen 44th Annual Healthcare Conference on Tuesday, Mar. 5, at 2:50 p.m. EDT (11:50 a.m. PDT) in Boston, Massachusetts. A live webcast of the presentation will be available on the Events and Presentations page of Bolt’s website
Pacira Appoints Frank D. Lee as Chief Executive Officer
Posted on Thursday December 21, 2023
-- Transformational Leader Brings Three Decades of Global Experience in Pharmaceutical and Biotechnology Product Development and Commercialization -- -- Paul J. Hastings Named Chair of the Board -- -- Dave Stack to Remain in Advisory Role through August 2025 -- TAMPA, Fla., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced that its Board of Directors (th
Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®
Posted on Tuesday December 05, 2023
BDC-1001 is a Boltbody™ Immune-Stimulating Antibody Conjugate (ISAC) in Phase 2 development for HER2-positive breast, colorectal, endometrial, and gastroesophageal cancersPoster detailing trial design and rationale to be presented at the 2023 San Antonio Breast Cancer Symposium on Wednesday, December 6 REDWOOD CITY, Calif., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc. (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of